Effect of sodium-glucose cotransporter-2 (SGLT2) inhibitors on serum urate levels in patients with and without diabetes: a systematic review and meta-regression of 43 randomized controlled trials

• Κύριοι συγγραφείς: Alicia Swee Yan Yip (Συγγραφέας), Shariel Leong (Συγγραφέας), Yao Hao Teo (Συγγραφέας), Yao Neng Teo (Συγγραφέας), Nicholas L. X. Syn (Συγγραφέας), Ray Meng See (Συγγραφέας), Caitlin Fern Wee (Συγγραφέας), Elliot Yeung Chong (Συγγραφέας), Chi-Hang Lee (Συγγραφέας), Mark Y. Chan (Συγγραφέας), Tiong-Cheng Yeo (Συγγραφέας), Raymond C. C. Wong (Συγγραφέας), Ping Chai (Συγγραφέας), Ching-Hui Sia (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: SAGE Publishing, 2022-03-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Objectives: Sodium-glucose cotransporter-2 (SGLT2) inhibitors have been found to reduce serum urate in patients with type 2 diabetes mellitus. To evaluate if this effect applies to both patients with and without diabetes, we conducted a systematic review and meta-analysis of SGLT2 inhibitors on seru...